Veterans test CBD for pain relief in new study

NCT ID NCT06213233

Recruiting now Symptom relief Sponsor: Kevin Boehnke Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether cannabidiol (CBD), a compound from cannabis, can ease chronic pain in 468 veterans. Participants take either CBD or a placebo for 28 days and report their pain levels. The goal is to see if CBD improves pain symptoms better than a dummy pill.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cannabidiol (CBD, Epidiolex)
What this could lead to: If it works, this could point toward a safe, non-opioid option for managing chronic pain in veterans.
What could go wrong: This is a mid-stage trial with a short 28-day treatment period, so long-term benefits are unknown. CBD may not outperform placebo, and individual responses vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAIN, CHRONIC

Contacts and locations

Locations

University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.